CAS: 1029044-16-3 - Plx 3397

Formula: C₂₀H₁₅ClF₃N₅

InChI: InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)

InChI key: InChIKey=JGWRKYUXBBNENE-UHFFFAOYSA-N

SMILES: FC(F)(F)C1=NC=C(C=C1)CNC2=NC=C(C=C2)CC3=CNC=4N=CC(Cl)=CC43

N-[5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-3-pyridinemethanamine

CAS: 1029044-16-3

• Formula: C₂₀H₁₅ClF₃N₅
• Purity: 98%
• Color and Shape: Solid
• Molecular weight: 417.8148

Pexidartinib

CAS: 1029044-16-3

• Formula: C₂₀H₁₅ClF₃N₅
• Molecular weight: 417.81

Pexidartinib (PLX3397)

CAS: 1029044-16-32040295-03-0

• Formula: C₂₀H₁₅ClF₃N₅
• Molecular weight: 417.82

Pexidartinib

CAS: 1029044-16-3

Pexidartinib (PLX-3397) is a capsule formulation containing a small-molecule receptor tyrosine kinase (RTK) inhibitor of …

• Formula: C₂₀H₁₅ClF₃N₅
• Purity: 99.66%
• Color and Shape: Solid
• Molecular weight: 417.81

Pexidartinib

CAS: 1029044-16-3

Inhibitor of CSF1R receptor

• Formula: C₂₀H₁₅ClF₃N₅
• Purity: Min. 95%
• Color and Shape: Powder
• Molecular weight: 417.81 g/mol